Haohai Biotech announced that on September 2, 2026, the company repurchased 9100 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.63 to HK$16.68, with a total cost of HK$151,600, and the repurchased shares were to be cancelled. The repurchased shares accounted for 0.004% of the total number of H shares issued on the day the repurchase authorization resolution was passed. The company's repurchase authorization was approved on May 29, 2026. The maximum number of H shares that can be repurchased is 3.478 million shares. Up to now, 652,500 shares have been repurchased, accounting for 1.88% of the authorized limit. Matters such as issuing new shares after the repurchase will be suspended until October 2, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.